Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk
Rajkumar Savai(Goethe University Frankfurt), Werner Seeger(Justus-Liebig-Universität Gießen), Nefertiti El-Nikhely(Max Planck Institute for Heart and Lung Research), Janine Wolf(Justus-Liebig-Universität Gießen), Baktybek Kojonazarov(Cardio-Pulmonary Institute), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Andreas Weigert(Goethe University Frankfurt), Henning Gall(German Center for Lung Research), Stefan Gattenlöhner(Justus-Liebig-Universität Gießen), Samantha Storn(Max Planck Institute for Heart and Lung Research), Gabriele A. Krombach(Justus-Liebig-Universität Gießen), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Ylia Salazar(Max Planck Institute for Heart and Lung Research), Ulf R. Rapp(Max Planck Institute of Biochemistry), Ludger Fink(Institute of Cytology)
Cited by 102
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784